Journal ArticleOPEN ACCESS

Pegylated interferon-α for treating chronic hepatitis e virus infection after liver transplantation

Clinical Infectious Diseases (2010) 50(5)
DOI: 10.1086/650488
184Citations
Citations of this article
77Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study assessed the effect of a 3-month course of pegylated interferon-α-2a (Peg-IFN-α-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after PegIFN-α-2a therapy was completed. A relapse was observed in the third patient. © 2010 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Kamar, N., Rostaing, L., Abravanel, F., Garrouste, C., Esposito, L., Cardeau-Desangles, I., … Izopet, J. (2010). Pegylated interferon-α for treating chronic hepatitis e virus infection after liver transplantation. Clinical Infectious Diseases, 50(5). https://doi.org/10.1086/650488

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free